Sign in
4

Changes in Ownership

Immunovant, Inc. Filed Acc 0001415889-25-012047

Chief Financial Officer acquired 208,388 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Girao Tiago Chief Financial Officer 2025-05-01 Grant or award +208,388 208,388 D
Derivatives
Girao Tiago Chief Financial Officer 2025-05-01 Grant or award · Stock Option (Right to Buy) +293,505 293,505 D
Loading xslF345X05/form4-05052025_070505.xml…